LEMAITRE VASCULAR, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $776.00K, a 55.91% decline year-over-year.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $2.95M, a 125.00% increase year-over-year.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.58M, a 252.00% increase year-over-year.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.76M, a 141.10% increase year-over-year.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $6.82M, a 5.96% increase from fiscal 2024.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $6.44M, a 4.36% increase from fiscal 2023.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $6.17M, a 78.02% increase from fiscal 2022.
- LEMAITRE VASCULAR, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $3.47M, a 23.76% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $776.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $2.95M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $6.82M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $1.58M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $1.76M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $1.31M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $6.44M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $450.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $730.00K 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $3.99M 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $6.17M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $3.63M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $1.45M 10-Q · filed 2024-11-08 | |
| 2022-12-31 | $3.47M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $1.01M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $164.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $508.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $4.55M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $299.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.19M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $1.39M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $5.97M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $1.16M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $42.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $233.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $4.86M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $2.13M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $531.00K 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $479.00K 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $2.97M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $2.07M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $446.00K 10-Q · filed 2019-11-08 | |
| 2018-03-31 | $293.00K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $5.50M 10-K · filed 2020-03-12 | |
| 2016-12-31 | $1.44M 10-K · filed 2019-03-11 | |
| 2015-12-31 | $4.84M 10-K · filed 2018-03-09 | |
| 2014-12-31 | $343.00K 10-K · filed 2017-03-09 | |
| 2013-12-31 | $1.22M 10-K · filed 2016-03-10 | |
| 2012-12-31 | $358.00K 10-K · filed 2015-03-18 | |
| 2011-12-31 | $68.00K 10-K · filed 2014-03-21 | |
| 2010-12-31 | $131.00K 10-K · filed 2013-03-27 | |
| 2009-12-31 | $157.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |